IRCT20240308061212N1招募中3 期
Investigating the effect of tetrabenazine in the treatment of tardive dyskinesia in psychiatric patients
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •Having a diagnosis of tardive dyskinesia disorder
- •Having at least one diagnosis of mood or psychotic disorders
- •Having the ability to give informed consent
- •Having a minimum age of 18 years and a maximum age of 65 years
排除标准
- •History of neurological diseases such as epilepsy, Parkinson's, stroke and ischemic cardiac problems
- •History of tetrabenazine allergy
研究者
相似试验
尚未招募
不适用
Bioequivalence study of Tetrabenazine Tablet 25 mg manufactured by Hoogar Daru company-.IRCT20200625047913N4Hezareh Sevom Futuristic Pharmacist24
招募中
1 期
A trial to evaluate the efficacy, safety and tolerability of (+)-a-dihydrotetrabenazine for treatment of Tardive DyskinesiaTardive dyskinesiaEUCTR2022-001685-35-SKAdeptio Pharmaceuticals Limited102
No Longer Available
不适用
Compassionate Use of Tetrabenazine in the Treatment of Abnormal MovementsHyperkinetic Movement DisordersNCT00642057Joseph Jankovic
招募中
不适用
A prospective randomized controlled study of the efficacy of tetramethylpyrazine combined with Bupi Yishen Heat-sensitive Moxibustion on chronic kidney disease stages1-3chronic kidney diseaseITMCTR2200006598Jiujiang Hospital of Traditional Chinese Medicine
尚未招募
3 期
Investigation of the effect of Trimetazidine in patients with Aluminum phosphide poisoningIRCT20211017052794N1Shahid Beheshti University of Medical Sciences30